Kamen; Robert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kamen; Robert.The latest application filed is for "method and systems for prediction of hla class ii-specific epitopes and characterization of cd4+ t cells".

Company Profile

5.5.14

Kamen; Robert - Sudbury MA
Kamen; Robert - Toronto CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method And Systems For Prediction Of Hla Class Ii-specific Epitopes And Characterization Of Cd4+ T Cells App 20220199198 - Rooney; Michael Steven ; et al.	2022-06-23
Method and systems for prediction of HLA class II-specific epitopes and characterization of CD4+ T cells Grant 11,183,272 - Rooney , et al. November 23, 2	2021-11-23
Syringe Shield, Syringe Shipping And Administration System, And Components Therefor App 20210353859 - Kamen; Robert ; et al.	2021-11-18
Compression Member For Biohazardous Material Transporting Pig App 20210005337 - Kamen; Robert	2021-01-07
Method And Systems For Prediction Of Hla Class Ii-specific Epitopes And Characterization Of Cd4+ T Cells App 20200279616 - Rooney; Michael Steven ; et al.	2020-09-03
Biohazardous Material Transporting Pig App 20190348187 - KAMEN; Robert	2019-11-14
High Affinity Adaptor Molecules For Redirecting Antibody Specifity App 20160251400 - Collinson; Albert ; et al.	2016-09-01
High affinity adaptor molecules for redirecting antibody specifity Grant 9,284,548 - Collinson , et al. March 15, 2	2016-03-15
Low dose methods for treating disorders in which TNF.alpha. activity is detrimental Grant 8,846,046 - Kaymakcalan , et al. September 30, 2	2014-09-30
Low Dose Methods For Treating Disorders In Which Tnf-alpha Activity Is Detrimental App 20140200332 - Kaymakcalan; Zehra ; et al.	2014-07-17
High Affinity Adaptor Molecules For Redirecting Antibody Specifity App 20120271033 - Collinson; Albert ; et al.	2012-10-25
Low dose methods for treating disorders in which TNFalpha activity is detrimental App 20040166111 - Kaymakcalan, Zehra ; et al.	2004-08-26

Company Registrations

SEC

0001693540

Kamen Robert

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.